Overview
JAGX market data
Price History
JAGX price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for JAGX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · Jul 23, 2026, 5:05 PM
Jaguar Health Portfolio Company Napo Pharmaceuticals Provides Its Novel Crofelemer Powder To Treat Intestinal Failure From Microvillus Inclusion Disease In The EU For Compassionate UseBenzinga · Jul 22, 2026, 1:05 PM
Jaguar Health Registered Resale Of Up To 40.8M Shares Of Common Stock By Selling StockholderBenzinga · Jul 16, 2026, 10:10 AM
Jaguar Health Registered Resale Of Up To 40.8M Shares Of Common Stock By Selling StockholdeBenzinga · Jul 16, 2026, 10:09 AM
8-K filing — Jaguar Health, Inc. (JAGX)SEC EDGAR · Jul 14, 2026, 8:15 PM
Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Billion, Camp Mystic BankruptcyBenzinga · Jun 26, 2026, 5:55 PM
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand ViewingGlobenewswire Inc · Jun 26, 2026, 1:15 PM
Jaguar Health Submits New Animal Drug Application To FDA For Veterinary Medicine For Full Approval Of Crofelemer To Treat Chemotherapy-Induced Diarrhea In DogsBenzinga · Jun 23, 2026, 1:10 PM
8-K/A filing — Jaguar Health, Inc. (JAGX)SEC EDGAR · Jun 22, 2026, 8:25 PM
Jaguar Health Board Initiates Process To Mull, Review Strategic OptionsBenzinga · Jun 22, 2026, 1:55 PM